| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |